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The 3’-terminal sequence of tomato aspermy virus (TAV, a cucumovirus) RNA can be arranged in an ‘L’- 
shaped conformation similar to that of the 3’-tRNA-like regions of the tyrosine-accepting bromo-, cucumo- 
and hordeivirus RNAs examined to date. We report here that TAV RNA is recognized by the tRNA nucleo- 
tidyltransferase and can be adenylated nearly as efficiently as brome mosaic virus (BMV, a bromovirus) 
RNA. However, using tyrosyl-tRNA synthetase from rat liver or from yeast, TAV RNA cannot be tyrosyl- 
ated under conditions that allow aminoacylation of BMV RNA. Structural features in the 3’-region could 
be responsible for the recognitory discrimination between the BMV and TAV RNAs by these eukaryotic 
tyrosyl-tRNA synthetases. 
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1. INTRODUCTION 
The genome of several plant RNA viruses is said 
to possess a tRNA-like structure at its 3’-end since 
it is efficiently recognized in vitro by many tRNA- 
specific enzymes (for reviews, see [l-3]). 
Bromoviruses such as brome mosaic virus (BMV), 
broad bean mottle virus (BBMV) and cowpea 
chlorotic mottle virus (CCMV), cucumber mosaic 
virus (CMV, a cucumovirus) and barley stripe 
mosaic virus (BSMV, a hordeivirus) have a tripar- 
tite genome &id the three RNAs (designated RNA 
1, 2 and 3) that make up the genome of a given 
virus are all aminoacylatable at their 3 ‘-terminus 
with tyrosine. A comparison of the nucleotide se- 
quence of the 3 ‘-region of these viral RNAs has 
revealed striking intraviral and interviral 
homologies between these untranslated regions, 
even though the coding regions which precede 
them are totally different. This is particularly ap- 
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parent when comparing the tRNA-like regions of 
the bromovirus RNAs and of the CMV RNAs [4]. 
The folding of the 3 ’ -region of the BMV RNAs in 
their tRNA-like configuration, recently established 
[4-61, is presented in fig. 1A; this folding can be 
extended to the other tyrosine-accepting viral 
RNAs [5,7]. 
It has been proposed that the 3’-terminal 
nucleotide sequence of tomato aspermy virus 
(TAV, a cucumovirus with a tripartite RNA 
genome) RNA [8] can also be arranged [5] in a 
similar ‘L’-shaped conformation (fig.lB). How- 
ever, it is not known whether TAV RNA possesses 
tRNA-like properties. We have therefore examined 
whether the tRNA nucleotidyl transferase and the 
tyrosyl-tRNA synthetase can adenylate and amino- 
acylate TAV RNA as efficiently as BMV RNA, 
used as control. 
2. MATERIALS AND METHODS 
Total TAV RNA was generously supplied by 
R.H. Symons (University of Adelaide) and total 
BMV RNA by P.A. Verduin (University of 
Wageningen). Purified Escherichia coli tRNA 
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Fig.1. The tRNA-like structure of BMV RNA (A) and 
possible folding of the 3 ‘-region of TAV RNA (B). The 
sequences shown are those of RNA 3. Every 20th 
nucleotide isnumbered starting from the 3 ’ -end. I-IV in 
the BMV RNA structure correspond to stems and loops, 
and also refer to the corresponding stems and loops in 
the TAV RNA structure. Adapted from [S]. 
nucleotidyltransferase was a kind gift from D.S. 
Eustbe-Car& Highly purified tyrosyl-tRNA syn- 
thetase from rat liver was kindly provided by F. 
De&k (Institute of Biochemistry, Szeged), and 
from yeast by H. Faulhammer (University of 
Bayreuth). [‘H]ATP (31.7 Ci/mmol) was from 
Amersham (England) and [3H]tyrosine (60 Ci/ 
mmol) from the Centre de I’Energie Atomique 
(France). 
2.1. Preparation of viral RNA-CCon 
The 3 ‘-terminal A residue in TAV and BMV 
RNAs was removed by sodium periodate, aniline 
and alkaline phosphatase treatments as described 
PI. 
2.2. Adenylation and aminoacylation of viral 
RNAs 
Adenylation (20 ~1) was performed using 50 mM 
Tris-HCI, pH 9, 10 mM MgC12, 10 mM dithio- 
threitol (DTT), 10 ,&i [3H]ATP, 1Opg TAV or 
BMV RNA-CCon, 6 /cg tRNA nucleotidyltrans- 
ferase, and where indicated 50 mM KCl, for 
15 min at 37°C. 
Aminoacylation (20 /cl) was performed using 
50 mM Tris-HCI, pH 7.5 or pH 9, 10 mM MgCL, 
10 mM DTT, 2 mM ATP, 10,&i [3H]tyrosine, 
1Opg TAV or BMV RNA, tyrosyl-tRNA syn- 
thetase from rat liver (0.2rg) or from yeast 
(O.O2pg), and where indicated 50 mM KCl, for 
15 min at 37°C. 
The reactions were stopped by cold 10% 
trichloroacetic acid, the acid-precipitable radioac- 
tivity was determined and background levels ob- 
tained in the absence of added RNA were sub- 
tracted. It was verified that both adenylation and 
aminoacylation had reached the plateau level 
under these conditions. 
3. RESULTS 
3.1. Tyrosylation 
Contrary to what is observed with BMV RNA, 
TAV RNA is virtually not aminoacylated by the 
tyrosyl-tRNA synthetase from either rat liver or 
yeast (table 1) or sheep liver (not shown). The level 
of aminoacylation of BMV RNA by the rat liver 
enzyme in the absence of KC1 was considerably 
higher at pH 7.5 than at pH 9; the reverse was true 
with the yeast enzyme. This level of aminoacyla- 
tion could be increased by the addition of 50 mM 
KC1 in most assay conditions. However, virtually 
no tyrosylation of TAV was observed under any of 
these conditions. Since the proportion of the dif- 
ferent viral RNAs extracted from different virus 
preparations is subject to variations, and since 
total unfractionated viral RNAs were used here, 
quantitation of the yield of aminoacylation (and 
adenylation, see below) is subject to considerable 
error. Nevertheless, if one assumes that the 
average M, of the mixture of RNA components in 
BMV and TAV is comparable, aminoacylation of 
TAV RNA was at best -5% that of BMV RNA. 
The observation that BMV RNA is efficiently 
aminoacylated by the yeast enzyme is at variance 
with previous results [9] and could be due to the 
158 
Volume 194, number 1 FEBS LETTERS January 1986 
Table 1 
Tyrosylation of TAV and BMV RNA? 
Source of 
RNA 
KC1 
(SO mM) 
[3H]Tyrosine bound (cpm) 
pH 7.5 pH9 
TAV 
+ 
Enzyme source 
Rat liver Yeast 
1250 670 
1460 1160 
Enzyme source 
Rat liver Yeast 
1400 400 
1780 1650 
BMV 68190 47 170 34300 72740 
+ 85960 121380 37 340 138340 
a 1 pmol Tyr-RNA corresponds to -20000 cpm 
high specific activity of the yeast tyrosyl-tRNA 
synthetase used here. 
3.2. Adenylation 
Since BMV RNA is also recognized by the tRNA 
nucleotidyltransferase [S], an enzyme with less 
stringent requirements than aminoacyl-tRNA syn- 
thetases, we have examined whether TAV RNA 
could be a substrate for this tRNA-specific en- 
zyme. TAV and BMV RNAs as extracted from the 
virus terminate at their 3 ‘-end by the sequence 
-CCA. Upon removal of the 3 ‘-terminal A residue, 
the tRNA nucleotidyltransferase can indeed 
adenylate TAV RNA-CC& nearly as efficiently as 
BMV RNA-CCou, as seen in table 2. The adenyla- 
tion experiments were performed at pH 9, i.e. close 
to the optimal pH value reported for this enzyme 
[lo]. Indeed, when performed at pH 7.5 (50 mM 
Tris-HCl) adenyIation was about 35 and 25% of 
Table 2 
Adenylation of TAV and BMV RNA-CCOH’ 
Source of KC1 [‘HIAMP incor~rated 
RNA-CCOH (50 mM) @pm) 
TAV - 37 120 
+ 24120 
BMV 44360 
+ 31310 
a 1 pm01 AMP incorporated corresponds to 
-10000 cpm 
the value obtained at pH 9 for the TAV and BMV 
RNAs, respectively (not shown). As expected [I 11, 
the presence of KC1 reduced the level of adenyla- 
tion of both viral RNAs. Our positive results con- 
cerning the recognition of TAV RNA by the tRNA 
nucleotidyltransferase suggest hat TAV RNA has 
at least retained the tRNA-like features required 
for adenylation, and supports folding of this 
region of the viral RNA as proposed previously 
[5], and as presented in fig.lB. 
4. DISCUSSION 
One immediate apparent difference between the 
TAV and BMV RNAs resides in the stem and loop 
IV which in TAV RNA are about twice as long as 
in BMV RNA (and in the CCMV and CM i4,5] 
RNAs). This could be an element of hindrance for 
recognition of TAV RNA by the rat liver or yeast 
tyrosyl-tRNA synthetase. It is interesting to point 
out that stem and loop IV are absent from the 
tRNA-like regions of the BBMV [4,5] and BSMV 
[7] RNAs, and thus are not mandatory for 
tyrosylation. However, other features, such as 
nucleotide sequence and/or local confo~ations 
could be responsible for the lack of recognition of 
TAV RNA by the tyrosyl-tRNA synthetases used 
here. Furthermore, aminoacylation of TAV RNA 
by tyrosyl-tRNA synthetases from other origins 
cannot be ruled out. 
The biological function of the tRNA-like struc- 
tures in plant viral RNAs still remains enigmatic. 
It has been reported that the BMV and BSMV 
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protoplasts [ 121. Were TAV not to be 
aminoacylated in vivo, this would be an important 
fact that would have to be taken into account when 
considering a general role of the tRNA-like struc- 
tures in these viral RNAs. 
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